2017 American Transplant Congress
Interruption of RAAS in Hypertensive Proteinuric Kidney Donors.
The aim of this analysis was to assess the progression of eGFR between proteinuric hypertensive living kidney donors (HTN-LKDs) receiving ACE inhibitors (ACEinh) or angiotensin…2017 American Transplant Congress
Impact of Antihypertensive (AHT) Choice and Advagraf® Dose on Interstitial Fibrosis/Tubular Atrophy (IF/TA) and IF/TA Progression in Renal Allografts 24 Months Post-Transplantation (Tx).
IF/TA may be delayed using ACEi- or ARB-type AHTs, which target the renin-angiotensin system (RAS), as well as by optimizing tacrolimus (TAC) exposure. The effect…2017 American Transplant Congress
Left-Sided Donor Nephrectomy Predisposes Living Kidney Donors to Latent Adrenal Insufficiency with Symptoms of Fatigue and Inferior Quality of Life.
The rising prevalence of end-stage renal disease and chronic organ shortage calls more people upon to consider living kidney donation. The benefits for recipients and…2017 American Transplant Congress
Renal Function Outcomes of Hypertensive Living Kidney Donors (HLD) and Recipients of HLD Kidneys: Results of a Case-Control Study.
1Nephrology, Ohio State, Columbus, OH; 2Transplant, Ohio State, Columbus, OH
As the shortage of suitable deceased and living kidney donors (LD) persists, medically complex LD, including those with hypertension (HTN), are being considered for donation…2017 American Transplant Congress
Angioplasty versus Stent in the Treatment of Transplant Renal Artery Stenosis.
Objective: To compare restenosis rates and treatment efficacy between percutaneous transluminal angioplasty and stent placement in the treatment of transplant renal artery stenosis.Methods: We conducted…2017 American Transplant Congress
Identify Clinical and Masked Hypertension and Management Strategies in Pediatric Liver Transplant Patients.
BACKGROUND: Hypertension (HTN) occurs after solid organ transplant and may have an impact on future cardiovascular disease and associated co-morbidities. Little has been reported on…2017 American Transplant Congress
Porta Systemic Shunts Helps Us to Delay or Avoid Liver Transplantation in Patients with Portal Hypertension Post Kasai Operation for Biliary Atresia.
Paediatric Surgery and Transplant Surgery, Children's Hospital at Westmead, Sydney, NSW, Australia
We present a series of 10 patients who had Kasai operation for biliary atresia in the neonatal period. These patients had optimally functioning liver in…2017 American Transplant Congress
Pulse Pressure After Renal Transplantation – Influence on Outcome: Results from the Collaborative Transplant Study.
Systolic blood pressure (SBP) and diastolic blood pressure (DBP) are important predictors of graft and patient survival in renal transplant recipients. Pulse pressure (PP), the…2017 American Transplant Congress
Albuminuria in Kidney Transplant Patients Is Associated with Increased Urine Serine Proteases with the Ability to Activate ENaC.
Background In patients with renal transplant albuminuria is associated with salt-sensitive hypertension. Aberrantly filtered serine proteases e.g. plasmin has shown to activate ENaC through proteolytic…2017 American Transplant Congress
Superior Long-Term Hypertension Management in Pediatric Kidney Transplant Recipients with Bilateral Native Nephrectomies.
Introduction: Native nephrectomy in pediatric kidney transplant recipients is performed for congenital anomalies, proteinuria, intractable hypertension, malignancy, and chronic infection. Post-transplant hypertension requiring medical management…
- « Previous Page
- 1
- …
- 4
- 5
- 6
- 7
- 8
- Next Page »